2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.ome ga.-pentanorprostaglandins
US3932389A · kind A · utility
15Cited by
1References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 11, 1974 |
| Grant date | Jan 13, 1976 |
| Priority date | — |
| Expiry date | Dec 11, 1994 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6524
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorpr ostaglandins and various intermediates employed in their preparation. The novel prostaglandins of this invention have been found to have activity profiles comparable to the parent prostaglandins, but exhibit a greater tissue specificity of action.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.